Clinical Cancer Research Versailles No Abst Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, N.
Right arrow Articles by Tanaka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, N.
Right arrow Articles by Tanaka, M.
Clinical Cancer Research Vol. 5, 963-970, May 1999
© 1999 American Association for Cancer Research


Advances in Brief

Centrosome Abnormalities in Pancreatic Ductal Carcinoma

Norihiro Sato, Kazuhiro Mizumoto1, Masafumi Nakamura, Kenjiro Nakamura, Masahiro Kusumoto, Hideaki Niiyama, Takahiro Ogawa and Masao Tanaka

Department of Surgery I, Kyushu University Faculty of Medicine, Fukuoka 812-8582, Japan

The centrosome plays an important role in microtubule nucleation and organization, ensuring the establishment of cell polarity and balanced chromosome segregation. Recent studies have suggested that the loss of cell polarity and/or chromosome missegregation (aneuploidy) in human malignant tumors could result from defects in centrosome function. Using immunofluorescence analysis with an antibody to {gamma}-tubulin (a well-characterized centrosomal component), we examined surgically resected human pancreatic tissues for centrosome abnormalities. The tissues included ductal carcinomas (n = 13), adenomas (n = 3), endocrine tumors (n = 3), chronic pancreatitis (n = 5), and normal pancreatic tissues (n = 12). We found that most (85%) carcinomas and some adenomas displayed abnormal centrosome profiles, characterized by an increase in size and number of centrosomes, and by their irregular distribution. In contrast, none of normal ductal and stromal tissues showed these abnormalities. These findings suggest that centrosome abnormalities may develop at a relatively early stage of pancreatic ductal carcinogenesis.




This article has been cited by other articles:


Home page
BloodHome page
W. J. Chng, E. Braggio, G. Mulligan, B. Bryant, E. Remstein, R. Valdez, A. Dogan, and R. Fonseca
The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition
Blood, February 1, 2008; 111(3): 1603 - 1609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. D. Slack, Z. Chen, A. D. Ludwig, J. Hicks, and J. M. Shohet
MYCN-Directed Centrosome Amplification Requires MDM2-Mediated Suppression of p53 Activity in Neuroblastoma Cells
Cancer Res., March 15, 2007; 67(6): 2448 - 2455.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho
Genetics and biology of pancreatic ductal adenocarcinoma.
Genes & Dev., May 15, 2006; 20(10): 1218 - 1249.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. J. Chng, G. J. Ahmann, K. Henderson, R. Santana-Davila, P. R. Greipp, M. A. Gertz, M. Q. Lacy, A. Dispenzieri, S. Kumar, S. V. Rajkumar, et al.
Clinical implication of centrosome amplification in plasma cell neoplasm
Blood, May 1, 2006; 107(9): 3669 - 3675.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Wang, X. Du, J. Meinkoth, Y. Hirohashi, H. Zhang, Q. Liu, M. Richter, and M. I. Greene
Characterization of Su48, a centrosome protein essential for cell division
PNAS, April 25, 2006; 103(17): 6512 - 6517.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Sugihara, M. Kanai, S. Saito, T. Nitta, H. Toyoshima, K. Nakayama, K. I. Nakayama, K. Fukasawa, M. Schwab, H. Saya, et al.
Suppression of Centrosome Amplification after DNA Damage Depends on p27 Accumulation.
Cancer Res., April 15, 2006; 66(8): 4020 - 4029.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Hida, Y. Hida, D. N. Amin, A. F. Flint, D. Panigrahy, C. C. Morton, and M. Klagsbrun
Tumor-Associated Endothelial Cells with Cytogenetic Abnormalities
Cancer Res., November 15, 2004; 64(22): 8249 - 8255.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Rojanala, H. Han, R. M. Munoz, W. Browne, R. Nagle, D. D. Von Hoff, and D. J. Bearss
The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer
Mol. Cancer Ther., April 1, 2004; 3(4): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Schaeffer, M. Nguyen, A. Liem, D. Lee, C. Montagna, P. F. Lambert, T. Ried, and M. J. Difilippantonio
E6 and E7 Oncoproteins Induce Distinct Patterns of Chromosomal Aneuploidy in Skin Tumors from Transgenic Mice
Cancer Res., January 15, 2004; 64(2): 538 - 546.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. A. Pihan, J. Wallace, Y. Zhou, and S. J. Doxsey
Centrosome Abnormalities and Chromosome Instability Occur Together in Pre-invasive Carcinomas
Cancer Res., March 15, 2003; 63(6): 1398 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Li, J. Zhu, P. F. Firozi, J. L. Abbruzzese, D. B. Evans, K. Cleary, H. Friess, and S. Sen
Overexpression of Oncogenic STK15/BTAK/Aurora A Kinase in Human Pancreatic Cancer
Clin. Cancer Res., March 1, 2003; 9(3): 991 - 997.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Neben, C. Giesecke, S. Schweizer, A. D. Ho, and A. Kramer
Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile
Blood, January 1, 2003; 101(1): 289 - 291.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.